Published in Mol Genet Metab on October 01, 1998
Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J Cell Biol (2001) 3.44
The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A (2000) 2.82
Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2014) 2.77
Rab27a regulates the peripheral distribution of melanosomes in melanocytes. J Cell Biol (2001) 2.76
Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol (2001) 2.74
Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet (2003) 1.69
AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell (2001) 1.60
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28
Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet (2003) 1.19
Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. Am J Respir Crit Care Med (2009) 1.15
Yeast homologues of three BLOC-1 subunits highlight KxDL proteins as conserved interactors of BLOC-1. Traffic (2011) 1.05
Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev (2014) 1.03
MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet (2003) 0.95
Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner. PLoS One (2009) 0.87
Hyperosmotic stress reduces melanin production by altering melanosome formation. PLoS One (2014) 0.81
Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. Ann Am Thorac Soc (2016) 0.76
Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell (1999) 4.67
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science (1982) 2.49
Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet (1994) 2.25
Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med (1993) 1.98
Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem (1982) 1.94
Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med (1987) 1.92
Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab (1999) 1.91
Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest (2000) 1.90
Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet (2001) 1.83
Early copper therapy in classic Menkes disease patients with a novel splicing mutation. Ann Neurol (1995) 1.82
The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost (2010) 1.73
Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol (1994) 1.70
Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med (1997) 1.63
Classic nephropathic cystinosis as an adult disease. JAMA (1993) 1.62
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell (2001) 1.60
Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet (2001) 1.56
Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol (1994) 1.55
Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene. J Biol Chem (2000) 1.51
Mutations in 3 genes (MKS3, CC2D2A and RPGRIP1L) cause COACH syndrome (Joubert syndrome with congenital hepatic fibrosis). J Med Genet (2009) 1.50
Indian childhood cirrhosis in an American child. Gastroenterology (1992) 1.47
The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci (2001) 1.46
CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet (1998) 1.41
Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. Science (1986) 1.41
Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med (1991) 1.41
Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr (1992) 1.40
Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J (1983) 1.40
Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic (2000) 1.40
Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost (2007) 1.40
NTBC and alkaptonuria. Am J Hum Genet (1998) 1.38
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32
Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol (1993) 1.32
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28
A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med (2000) 1.27
Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes. J Biol Chem (1982) 1.25
Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab (1995) 1.24
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21
Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab (1999) 1.21
Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion. Biochem Mol Med (1996) 1.20
Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet (1999) 1.16
A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res (1988) 1.14
Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med (2002) 1.14
Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet (1996) 1.10
Molecular cloning and characterization of human VPS18, VPS 11, VPS16, and VPS33. Gene (2001) 1.10
Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem (1989) 1.10
Transamination of methionine in humans. Clin Sci (Lond) (1989) 1.10
CTNS mutations in patients with cystinosis. Hum Mutat (1999) 1.09
Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol (1986) 1.09
Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J (1985) 1.08
Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res (2000) 1.07
Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.07
Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking. Lab Invest (1998) 1.07
Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am J Hum Genet (1984) 1.07
Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine. J Clin Endocrinol Metab (1985) 1.04
Recent advances in the treatment of cystinosis. J Inherit Metab Dis (1995) 1.04
Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol (1994) 1.04
Course of nephropathic cystinosis after age 10 years. J Pediatr (1986) 1.04
Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology (1995) 1.03
A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. Mol Genet Metab (1998) 1.02
Cystinosis coming of age. Adv Pediatr (1986) 1.02
Sialic acid metabolism in sialuria fibroblasts. J Biol Chem (1991) 1.02
Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease. J Inherit Metab Dis (1993) 1.01
Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med (1987) 1.00
Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol (1989) 1.00
Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99
Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem (2001) 0.99
Polyamine degradation in foetal and adult bovine serum. Biochem J (1982) 0.99
Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest (1985) 0.99
Clinical and cellular characterisation of Hermansky-Pudlak syndrome type 6. J Med Genet (2009) 0.98
Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost (2001) 0.98
Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase. Hum Genet (1994) 0.97
A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol (1990) 0.96
Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. J Biol Chem (1986) 0.96
Identification of the metabolic defect in sialuria. J Biol Chem (1989) 0.95
Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet (1997) 0.95
Carbohydrate-deficient glycoprotein syndrome. Adv Pediatr (1997) 0.95
A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. Mol Genet Metab (2001) 0.94
pH effects on cystine transport in lysosome-rich leucocyte granular fractions. Biochem J (1985) 0.94
Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13. Biochem Mol Med (1996) 0.94
Molecular cloning of two novel rab genes from human melanocytes. Gene (1996) 0.94
Pulmonary dysfunction in adults with nephropathic cystinosis. Chest (2001) 0.94
Clinical and molecular aspects of nephropathic cystinosis. J Mol Med (Berl) (1998) 0.94
Trafficking of major histocompatibility complex class II molecules in human B-lymphoblasts deficient in the AP-3 adaptor complex. Immunol Lett (2000) 0.93
Hepatic methionine adenosyltransferase deficiency in a 31-year-old man. Am J Hum Genet (1987) 0.93
P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome. J Med Genet (2004) 0.93
Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child (1987) 0.93
Nephropathic cystinosis: immunohistochemical and histopathologic studies of cornea, conjunctiva and iris. Curr Eye Res (1987) 0.92
Metabolism of pantethine in cystinosis. J Clin Invest (1985) 0.91
Swallowing dysfunction in nephropathic cystinosis. N Engl J Med (1990) 0.90
Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis. J Pediatr (1988) 0.90
CTNS mutations in African American patients with cystinosis. Mol Genet Metab (2001) 0.89
Dominant inheritance of sialuria, an inborn error of feedback inhibition. Am J Hum Genet (2001) 0.89
Cystinosis. Semin Nephrol (1989) 0.88
Hermansky-Pudlak syndrome: the importance of molecular subtyping. J Thromb Haemost (2010) 0.88
Three new mutations in a gene causing Hermansky-Pudlak syndrome: clinical correlations. Mol Genet Metab (1998) 0.88
The oculocerebrorenal syndrome of Lowe. Adv Pediatr (1991) 0.86
Clinical and biochemical studies in an American child with sialuria. Biochem Med Metab Biol (1993) 0.86
The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. Am J Hum Genet (2001) 0.86
Separation of putrescine oxidase and spermidine oxidase in foetal bovine serum with the aid of a specific radioactive assay of spermidine oxidase. Biochem J (1980) 0.86
Acetylated polyamines as substrates for human pregnancy serum diamine oxidase. Life Sci (1981) 0.85